Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing per Eoin Dinneen, Gregory L. Shaw, Roseann Kealy, Panos Alexandris, Kier Finnegan, Kimberley Chu, Nadia Haidar, Sara Santos‐Vidal, Sakunthala Kudahetti, Caroline M. Moore, Alistair D. R. Grey, Daniel M. Berney, Anju Sahdev, Paul J. Cathcart, R. Timothy D. Oliver, Prabhakar Rajan, Jack Cuzick, for the PROVENT study group

Obtenir text complet